Computer-assisted drug development (CADD): an emerging technology for designing first-time-in-man and proof-of-concept studies from preclinical experiments

By Gomeni R.   Bani M.   D'Angeli C.   Corsi M.   Bye A.  

European Journal of Pharmaceutical Sciences, Vol. 13, Iss. 3, 2001-06 ,pp. : 261-270

Elsevier

Access to resources Recommend Favorite

Anesthetic Cardioprotection in Clinical Practice From Proof-of-Concept to Clinical Applications

By  

Current Pharmaceutical Design, Vol. 20, Iss. 36, 2014-11 ,pp. : 5706-5726

Bentham Science Publishers

Access to resources Recommend Favorite

A Mechanism-Based Population Pharmacokinetic Model for Characterizing Time-Dependent Pharmacokinetics of Midostaurin and its Metabolites in Human Subjects

By Yin Ophelia Q.P.   Wang Yanfeng   Schran Horst  

Clinical Pharmacokinetics, Vol. 47, Iss. 12, 2008-01 ,pp. : 807-816

Adis International

Access to resources Recommend Favorite

Quantitative Prediction of Human Pharmacokinetics for Monoclonal Antibodies: Retrospective Analysis of Monkey as a Single Species for First-in-Human Prediction

By Dong Jennifer Q.  

Clinical Pharmacokinetics, Vol. 50, Iss. 2, 2011-02 ,pp. : 131-142

Adis International

Access to resources Recommend Favorite

Appropriate Empirical Antibacterial Therapy for Nosocomial Infections: Getting it Right the First Time

By Kollef M.H.  

Drugs, Vol. 63, Iss. 20, 2003-01 ,pp. : 2157-2168

Adis International

Access to resources Recommend Favorite